<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41759">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01769924</url>
  </required_header>
  <id_info>
    <org_study_id>A092761</org_study_id>
    <nct_id>NCT01769924</nct_id>
  </id_info>
  <brief_title>A Prospective UK Multicentre Study of Kidney Donors</brief_title>
  <official_title>Effect of A Reduction in Glomerular Filtration Rate After Nephrectomy on Arterial Stiffness (EARNEST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>British Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Birmingham NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North Bristol NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals Coventry and Warwickshire NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kings Health Partners</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Glasgow Western Infirmary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Belfast City Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sheffield Teaching Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cambridge University Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies of patients with established kidney disease, even when this is mild, appear to show
      that they are at high risk of heart failure, stroke and sudden cardiac death. This may be
      because kidney disease causes stiffening of the arteries in the body which means that the
      heart and brain are damaged by high blood pressure. By studying patients before and after
      the removal of a kidney (uni-nephrectomy) for transplantation the investigators will find
      out for the first time in man the effect of an isolated reduction in kidney function on the
      structure and function of the cardiovascular system.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2013</start_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Aortic Pulse Wave Velocity (aPWV) adjusted for mean arterial pressure and heart rate</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>24 hour ambulatory systolic blood pressure</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinic blood pressure</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients newly diagnosed with hypertension</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>As defined by commencement of antihypertensive therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Augmentation index (AIx)</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central blood pressure</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Central haemodynamics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>N-terminal prohormone of brain natriuretic peptide (NT-proBNP)</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary albumin: creatinine ratio (ACR)</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">880</enrollment>
  <condition>Living Kidney Donors</condition>
  <arm_group>
    <arm_group_label>Live kidney donors</arm_group_label>
    <description>Nephrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Nil</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nephrectomy</intervention_name>
    <arm_group_label>Live kidney donors</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine, serum and plasma.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A donor group will be recruited from all patients undergoing donor nephrectomy.

          -  A contemporaneous control group will be recruited from clinics, advertisements within
             and outside the institutions and from any local volunteer databases.

        Exclusion Criteria:

          -  These will be the same for donors and controls. The current nationally set exclusion
             criteria for donors include age/glomerular filtration rate (GFR) cutoff, diabetes
             mellitus, any history of cardiovascular or pulmonary disease, evidence of
             hypertensive end-organ damage, known left ventricular dysfunction (including ejection
             fraction &lt; 40%) and atrial fibrillation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Cockcroft, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Cardiff</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian B Wilkinson</last_name>
    <role>Study Director</role>
    <affiliation>Cambridge Heart Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jonathan N Townend</last_name>
    <role>Principal Investigator</role>
    <affiliation>Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan N Townend</last_name>
    <email>john.townend@uhb.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>William E Moody</last_name>
    <email>william.moody@nhs.net</email>
  </overall_contact_backup>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 15, 2013</lastchanged_date>
  <firstreceived_date>January 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Birmingham NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Jonathan N. Townend</investigator_full_name>
    <investigator_title>Consultant Cardiologist and Honorary Reader in Cardiology</investigator_title>
  </responsible_party>
  <keyword>kidney donors</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>blood pressure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
